Related Experiment Video
Updated: Mar 27, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.
Elizabeth R Volkmann1, Yu-Ling Chang1, Nashla Barroso1
1University of California, Los Angeles David Geffen School of Medicine.
Systemic sclerosis (SSc) patients exhibit a unique gut microbiome profile compared to healthy individuals. Specific bacterial changes in SSc correlate with gastrointestinal symptom severity.
Area of Science:
- Gastroenterology
- Microbiome research
- Immunology
Background:
- Systemic sclerosis (SSc) is an autoimmune disease with frequent gastrointestinal (GI) involvement.
- The colonic microbiome's role in SSc pathogenesis and symptoms is not fully understood.
Purpose of the Study:
- To compare colonic microbial composition between SSc patients and healthy controls.
- To identify specific microbial genera associated with GI symptoms in SSc.
Main Methods:
- 17 SSc patients and age/sex-matched healthy controls underwent colonoscopy.
- Cecum and sigmoid mucosal lavage samples were analyzed using 16S rRNA sequencing.
- Differential abundance analysis identified microbial differences and symptom associations.
Main Results:
- SSc patients showed distinct cecal and sigmoid microbial communities compared to controls (P=0.001).
- Decreased commensal bacteria (e.g., Faecalibacterium, Clostridium) and increased pathobionts (e.g., Fusobacterium, γ-Proteobacteria) were observed in SSc.
- Bifidobacterium and Lactobacillus were increased, while Bacteroides fragilis decreased in SSc patients with moderate/severe GI symptoms.
Conclusions:
- SSc patients possess a unique colonic microbial signature.
- These microbial alterations may contribute to SSc immunologic dysfunction and clinical symptoms.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Microbiota of the Large Intestine
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Microbiota of the Stomach and Small Intestine

